PHG Foundation Urges Continued Support for Host Genomics Research Amid Funding Cuts
The PHG Foundation emphasizes the critical importance of host genomics research in understanding infectious diseases, reiterating findings from its report published a year ago. Host genomics studies how human genetic variation influences susceptibility and outcomes of infections like tuberculosis, HIV, hepatitis C, and SARS-CoV-2. These insights are vital for developing vaccines, therapies, and risk stratification strategies. However, the field faces significant structural challenges, including fragmented research efforts and data bias toward European populations due to reliance on high-income country biobanks. The article highlights recent drastic changes in US research and public health funding, particularly freezes on foreign aid affecting programs like PEPFAR and USAID. These cuts threaten global health equity and hinder data collection for underrepresented populations in the Global South. The Foundation argues that diverse genomic data is a scientific imperative for improving the generalizability of medical innovations. It calls for a coordinated, sustainable approach to infrastructure and funding to overcome biological complexities and systemic barriers, ensuring that host genomics can fully contribute to combating infectious diseases globally despite shifting policy priorities.
Wire timeline
PHG Foundation Urges Continued Support for Host Genomics Research Amid Funding Cuts
The PHG Foundation emphasizes the critical importance of host genomics research in understanding infectious diseases, reiterating findings from its report published a year ago. Host genomics studies how human genetic variation influences susceptibility and outcomes of infections like tuberculosis, HIV, hepatitis C, and SARS-CoV-2. These insights are vital for developing vaccines, therapies, and risk stratification strategies. However, the field faces significant structural challenges, including fragmented research efforts and data bias toward European populations due to reliance on high-income country biobanks. The article highlights recent drastic changes in US research and public health funding, particularly freezes on foreign aid affecting programs like PEPFAR and USAID. These cuts threaten global health equity and hinder data collection for underrepresented populations in the Global South. The Foundation argues that diverse genomic data is a scientific imperative for improving the generalizability of medical innovations. It calls for a coordinated, sustainable approach to infrastructure and funding to overcome biological complexities and systemic barriers, ensuring that host genomics can fully contribute to combating infectious diseases globally despite shifting policy priorities.
PHG Foundation